Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px
Organisation › Details

Sucampo Pharmaceuticals Inc. (Nasdaq: SCMP)

Sucampo Pharmaceuticals, Inc., a specialty biopharmaceutical company based in Bethesda, Md, focuses on the development and commercialization of medicines based on prostones. The therapeutic potential of prostones, which are bio-lipids that occur naturally in the human body, was first identified by Ryuji Ueno, M.D., Ph.D., Ph.D., Sucampo Pharmaceuticals' chairman and chief executive officer. Dr. Ueno founded Sucampo Pharmaceuticals in 1996 with Sachiko Kuno, Ph.D., founding chief executive officer and advisor, international business development. *

 

Period Start 1996-01-01 established
  Group Mallinckrodt (Group)
Product Industry pharmaceutical
     
  Street 4520 East West Highway
3rd Floor
  City 20814 Bethesda, MD
  Tel +1-301-961-3400
    Address record changed: 2018-07-24
     
Basic data Employees n. a.
     
    * Document for �About Section�: 
     
   
Record changed: 2018-10-31

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Mallinckrodt (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px




» top